SCG3 and diabetes mellitus: Using a newly developed technology called ligandomics [14], we recently discovered secretogranin III (Scg3) as a diabetes-selective angiogenic and vascular leakage factor that preferentially binds to diabetic over healthy retinal vasculatures [15].